Please read and agree to the
terms and conditions
of this site.
I agree
COVID-19
/news
Clear filters and search
Format
photo
Tags
/innovation
breaking
breaking-news
coronavirus
games
health-care
innovation
politics
science
technology
What
authorization
criticism
2
×
emergency
fda
2
×
treatment
use
2
×
ags
approval
chief
clinical
combat
company
convalescent
coronavirus
costly
course
covid
drug
exclusive
final
gilead
gilead's
granted
hahn
insurance
justified
patients
plasma
positive
pricing
private
received
remarks
remdesivir
results
right
shouldn't
showing
state
trials
Language
unset
Current search:
criticism
×
fda
×
use
×
@axios.com
5 years ago
FDA chief Hahn says criticism of his remarks on plasma treatment for coronavirus "justified"
@forbes.com
5 years ago
State AGs Say Gilead Shouldn't Have Exclusive Right To Costly Remdesivir Treatment
